Novo-Nordisk stock falls after the close

At the close on September 23, 2026, Novo-Nordisk stock had fallen on the NYSE, while the S&P 500 declined 0.65 percent. The company also discussed a possible direct New York listing.

The U.S.-listed ADRs of Novo-Nordisk stock ended the regular session on the NYSE on September 23, 2026, with the session move reported at a lower level than the prior close. The S&P 500 fell 0.65 percent to 7,713.92 on the same date, providing a weaker market backdrop for the ADRs.

September 23, 2026 session in numbers

Novo Nordisk A/S (ISIN DK0062498333) remained primarily listed in Copenhagen, while its ADRs traded on the NYSE. Yahoo Finance reported that the company was open to a direct New York listing, but no timetable or formal proposal had been announced.

The Copenhagen-listed shares traded at DKK 257.50 on September 23, 2026, down 0.50 percent, with volume of 1,291,665 shares. That home-market data is not the U.S. closing value. The company presentation and long-term growth targets were cited as the backdrop for the recent share-price pressure by Reuters.

After the bell today

The next U.S. trading session follows on September 24, 2026. The direct-listing discussion remains the latest company-specific event cited for U.S. investors, while the S&P 500 closed down 0.65 percent on September 23, 2026.